PTC Therapeutics, Inc. (PTCT) Social Stream
PTC THERAPEUTICS INC (PTCT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PTCT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 8 | $85 | $38 | $58.625 | $40.35 | 45.29% |
| 2022-01-30 | 8 | $70 | $38 | $54.857 | $40.35 | 35.95% |
| 2022-02-22 | 8 | $70 | $34 | $54.285 | $40.35 | 34.54% |
| 2022-03-09 | 8 | $76 | $34 | $55.142 | $40.35 | 36.66% |
| 2022-04-01 | 7 | $76 | $34 | $55.143 | $40.35 | 36.66% |
| 2022-04-04 | 7 | $76 | $34 | $55 | $40.35 | 36.31% |
| 2022-04-12 | 7 | $76 | $34 | $54.285 | $40.35 | 34.54% |
| 2022-04-19 | 7 | $76 | $33 | $54.142 | $40.35 | 34.18% |
| 2022-05-04 | 7 | $79 | $33 | $54.571 | $40.35 | 35.24% |
| 2022-05-10 | 7 | $78 | $32 | $54 | $40.35 | 33.83% |
| 2022-05-23 | 7 | $78 | $34 | $54.285 | $40.35 | 34.54% |
| 2022-06-02 | 7 | $63 | $34 | $52.142 | $40.35 | 29.22% |
| 2022-06-21 | 7 | $63 | $35 | $52.285 | $40.35 | 29.58% |
| 2022-07-13 | 7 | $65 | $42 | $53.714 | $40.35 | 33.12% |
| 2022-08-08 | 7 | $69 | $42 | $54.285 | $40.35 | 34.54% |
| 2022-08-13 | 8 | $69 | $42 | $55.428 | $40.35 | 37.37% |
| 2022-09-01 | 9 | $70 | $42 | $57.25 | $40.35 | 41.88% |
| 2022-09-17 | 11 | $70 | $42 | $57.4 | $40.35 | 42.26% |
| 2022-10-12 | 11 | $70 | $42 | $57.5 | $40.35 | 42.5% |
| 2022-10-21 | 11 | $70 | $42 | $58.9 | $40.35 | 45.97% |
| 2022-10-28 | 11 | $70 | $36 | $56.9 | $40.35 | 41.02% |
| 2022-11-14 | 11 | $70 | $36 | $54.5 | $40.35 | 35.07% |
The Trend in the Analyst Price Target
Over the past 30 months, PTCT's average price target has gone down $5.94.
Over the past 42 weeks, PTCT's average upside potential has been 32.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 8 | 70 | 38 | 54.857 | 39.78 | 37.9% |
| 2022-01-30 | 8 | 70 | 38 | 54.857 | 39.03 | 40.55% |
| 2022-02-24 | 8 | 76 | 34 | 55.142 | 36.03 | 53.04% |
| 2022-04-19 | 7 | 76 | 33 | 54.142 | 43.53 | 24.38% |
| 2022-06-02 | 7 | 63 | 34 | 52.142 | 27.17 | 91.91% |
PTCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.91 | 6 | 1 | 3 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 28 months, PTCT's average broker recommendation rating worsened by 0.21.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PTC THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1608.36% of that group.
- In terms of how PTC THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 510.89% of that group.
- PTCT has a higher average analyst price target than 1827.86% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PTC THERAPEUTICS INC's number of analysts covering the stock is higher than 1643.27% of them.
In the Pharmaceutical Products industry, DVAX, OPK, and AMRN are the three stocks most similar to PTC THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!